HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Suhara Selected Research

KB R8301

2/2001Hypoxia stimulates release of the soluble form of fas ligand that inhibits endothelial cell apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Suhara Research Topics

Disease

5Schizophrenia (Dementia Praecox)
03/2012 - 08/2000
3Infections
07/2001 - 02/2000
2Mental Disorders (Mental Disorder)
02/2017 - 11/2001
2Alzheimer Disease (Alzheimer's Disease)
11/2015 - 05/2001
2Dementia (Dementias)
11/2015 - 07/2009
2Neoplasms (Cancer)
01/2008 - 03/2001
2Mood Disorders (Mood Disorder)
08/2001 - 11/2000
1Lewy Body Disease (Lewy Body Dementia)
07/2009
1Parkinson Disease (Parkinson's Disease)
07/2009
1Muscular Diseases (Myopathy)
05/2001
1Obesity
03/2001
1Hypoxia (Hypoxemia)
02/2001
1Bipolar Disorder (Manic Depressive Psychosis)
11/2000
1Hyperplasia
08/2000
1Epilepsy (Aura)
06/2000
1Temporal Lobe Epilepsy
06/2000
1Vascular Diseases (Vascular Disease)
02/2000
1Hypertension (High Blood Pressure)
01/2000

Drug/Important Bio-Agent (IBA)

3Fas Ligand Protein (Fas Ligand)IBA
02/2001 - 02/2000
2Dopamine (Intropin)FDA LinkGeneric
02/2017 - 03/2001
2AcetylcholinesteraseIBA
11/2015 - 07/2009
2Dopamine Receptors (Dopamine Receptor)IBA
11/2001 - 08/2001
2LithiumIBA
08/2001 - 11/2000
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2001 - 03/2001
2Messenger RNA (mRNA)IBA
02/2001 - 11/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2000 - 01/2000
1Acetates (Acetic Acid Esters)FDA Link
11/2015
1Therapeutic UsesIBA
03/2012
1Cholinergic Agents (Cholinergics)IBA
07/2009
1MethylcholanthreneIBA
01/2008
1SaltsIBA
08/2001
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2001
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
07/2001
1WortmanninIBA
07/2001
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
07/2001
1Peptides (Polypeptides)IBA
05/2001
1Amyloid beta-PeptidesIBA
05/2001
1EpitopesIBA
05/2001
1Glycogen Synthase Kinase 3IBA
03/2001
1Phosphatidylinositols (Phosphatidylinositol)IBA
03/2001
1Phosphotransferases (Kinase)IBA
03/2001
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
03/2001
1Proteins (Proteins, Gene)FDA Link
02/2001
1Oxygen (Dioxygen)IBA
02/2001
1KB R8301IBA
02/2001
1Risperidone (Risperdal Consta)FDA LinkGeneric
02/2001
1Neutralizing AntibodiesIBA
02/2001
1Metalloproteases (Metalloproteinases)IBA
02/2001
1Antipsychotic Agents (Antipsychotics)IBA
01/2001
1Tetracycline (Achromycin)FDA LinkGeneric
08/2000
1Nitric Oxide Synthase (NO Synthase)IBA
08/2000
1CreatineIBA
06/2000
1Protons (Proton)IBA
06/2000
1Phosphocreatine (Neoton)IBA
06/2000
1N-acetylaspartate (N-acetyl aspartate)IBA
06/2000
1Choline (Choline Chloride)IBA
06/2000
1CytokinesIBA
02/2000
1pranidipineIBA
01/2000

Therapy/Procedure

1Drug Therapy (Chemotherapy)
11/2001
1Subcutaneous Injections
08/2000
1Therapeutics
02/2000